Skip to main content

Instant redemption funds, UPI payments, KYC and more on the MobiKwik App!

Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

NAV on September 11, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Total Assets 1,565 cr
Turnover Ratio 65.05%
Expense Ratio 0.97%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: Negative return: -2.27%
  • 1Y: Positive return: 8.63%
  • 3M: Positive return: 6.67%
  • 3Y: Positive return: 19.67%
  • 6M: Positive return: 11.92%
  • 5Y: Positive return: 14.61%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since almost 2 years)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 40.58
P/B Ratio 6.28
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR

Asset Allocation

  • Equity: 99.5%
  • Debt: 0.5%
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -0.74
Beta 0.99
R-Squared 93.19
Info Ratio -0.28
Tracking Err 4.27
Sortino 1.489
Sharpe 0.889
Std Dev 16.377
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.51%
Industrial 0.0%
Technology 0.0%
Basic Materials 7.07%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 91.33%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 1.09%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

-

Best Sector Healthcare Funds

Name Latest NAV Returns 1y   Fund Assets Expense Ratio Risk
605.905 21.41% 5,796 cr 1.02% -
389.130 16.47% 1,444 cr 1.28% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata